David Tapolczay
Board Member
CDT Equity Inc. (CDT)Equibles does not estimate personal net worth.
Get an email with a short summary when CDT Equity Inc. publishes a filing, an earnings call transcript or a press release.
Get CDT alertsAbout David Tapolczay
David Tapolczay is recorded as CEO and Board Member at CDT Equity Inc. (CDT) since September 22, 2023. CDT Equity Inc. reported in an 8-K filed April 16, 2025 that David Tapolczay resigned as member of the Board, effective April 12, 2025. CDT Equity Inc. reported in an 8-K filed April 16, 2025 that David Tapolczay resigned as Chief Executive Officer, effective April 12, 2025. CDT Equity Inc. reported in an 8-K filed September 29, 2023 that David Tapolczay was appointed directors of the Company, effective September 22, 2023. Equibles holds 4 filed executive changes naming David Tapolczay; each is listed under recent activity with its source filing. The proxy statement of CDT Equity Inc. reports total compensation of $518,506 for David Tapolczay in fiscal 2025, including a base salary of $391,506. Disclosed compensation is on record for 4 fiscal years. CDT Equity Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CDT Equity Inc. includes Andrew Regan (CEO and Board Member), James Bligh (CEO, CFO and Board Member), Chele Chiavacci Farley (Chairman and Board Member) and 6 others.
“On April 12, 2025 (the "Effective Date"), David Tapolczay notified the Board of Directors (the "Board") of Conduit Pharmaceuticals Inc. (the "Company") of his resignation from both the Board and his position as Chief Executive Officer effective immediately.”
“On April 12, 2025 (the "Effective Date"), David Tapolczay notified the Board of Directors (the "Board") of Conduit Pharmaceuticals Inc. (the "Company") of his resignation from both the Board and his position as Chief Executive Officer effective immediately.”
Affiliation history
-
Current
2023-09-22–present
-
Current
2023-09-22–present
-
2023-09-22–2025-04-12
-
2023-09-22–2025-04-12
-
2023-01-01–2025-04-12
-
Start not stated–2025-04-12
Company network
Leadership on record at CDT Equity Inc.
- Andrew Regan CEO, Board Member
- James Bligh CEO, CFO, Board Member
- Chele Chiavacci Farley Chairman, Board Member
- Freda Lewis-Hall Chairman, Board Member
- Adam Sragovicz CFO
- Faith L. Charles Board Member
- Jennifer I. McNealey Board Member
- Simon Fry Board Member
- Ulrik Olsen Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CDT Equity Inc. (CDT) | Former Chief Executive Officer and Director and Current Head of Licensing & Strategy | $391,506 | $518,506 |
| 2024 | CDT Equity Inc. (CDT) | Former Chief Executive Officer | $558,578 | $617,378 |
| 2023 | CDT Equity Inc. (CDT) | Former Chief Executive Officer | $139,933 | $1,343,172 |
| 2022 | CDT Equity Inc. (CDT) | Chief Executive Officer and Director | — | — |